Search

everythinglearnresearchcommunity

for

Search:↓

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

New compounds may help treat prostate cancer by reducing cell growth.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Neural progenitor cell-derived nanovesicles help hair growth by activating a key signaling pathway.

Laser technologies improve medical treatments and outcomes.

Low-level laser therapy may help stem cells grow and function better, aiding in healing and tissue repair.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

The conclusion is that many small genetic variations influence claw disorders in cows, and using genomic selection could help reduce these disorders.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

A new gene, JMJD1C, may affect testosterone levels in men.

Insulin resistance linked to obesity may increase COVID-19 severity.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.